We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCYC
201
Bicycle Therapeutics
BCYC
$278M
$1.76M 0.05%
87,060
+2,080
+2% +$47K
BPMC
202
DELISTED
Blueprint Medicines
BPMC
$1.76M 0.05%
16,343
-1,657
-9% -$166K
CSLM
203
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$1.76M 0.05%
156,317
ADT icon
204
ADT
ADT
$5.59B
$1.75M 0.05%
229,607
PD icon
205
PagerDuty
PD
$856M
$1.72M 0.05%
75,000
+45,000
+150% +$938K
BKD icon
206
Brookdale Senior Living
BKD
$3.43B
$1.72M 0.05%
251,535
+142,535
+131% +$964K
PLD icon
207
Prologis
PLD
$130B
$1.72M 0.05%
+15,279
New +$1.69M
ADI icon
208
Analog Devices
ADI
$184B
$1.71M 0.05%
+7,500
New +$1.6M
ITUB icon
209
Itaú Unibanco
ITUB
$90.2B
$1.71M 0.05%
+330,871
New +$1.81M
CARG icon
210
CarGurus
CARG
$3.28B
$1.7M 0.05%
65,000
+40,000
+160% +$952K
AOGO
211
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$1.7M 0.05%
156,317
DXCM icon
212
DexCom
DXCM
$31.3B
$1.7M 0.05%
+15,000
New +$1.9M
ZG icon
213
Zillow
ZG
$7.72B
$1.69M 0.05%
37,500
-15,000
-29% -$647K
VEEA
214
Veea Inc
VEEA
$8.82M
$1.67M 0.05%
159,438
INCY icon
215
Incyte
INCY
$24B
$1.67M 0.05%
27,550
+11,300
+70% +$640K
DESP
216
DELISTED
Despegar.com
DESP
$1.65M 0.05%
+125,000
New +$1.65M
OCUL icon
217
Ocular Therapeutix
OCUL
$1.92B
$1.63M 0.05%
238,659
+50,081
+27% +$309K
FNVT
218
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$1.63M 0.05%
143,494
LRCX icon
219
Lam Research
LRCX
$383B
$1.6M 0.05%
+15,000
New +$1.44M
DOC icon
220
Healthpeak Properties
DOC
$14.5B
$1.59M 0.04%
81,046
+13,846
+21% +$264K
GTY
221
Getty Realty Corp
GTY
$2.06B
$1.56M 0.04%
58,428
+48,298
+477% +$1.31M
M icon
222
Macy's
M
$6.61B
$1.55M 0.04%
+80,801
New +$1.54M
EWTX icon
223
Edgewise Therapeutics
EWTX
$4.78B
$1.53M 0.04%
85,008
+9,911
+13% +$173K
LRMR icon
224
Larimar Therapeutics
LRMR
$436M
$1.51M 0.04%
207,783
+5,000
+2% +$38.3K
TER icon
225
Teradyne
TER
$60.2B
$1.48M 0.04%
+10,000
New +$1.27M

Similar funds

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.